Article
Clinical significance of genetic aberrations in secondary acute myeloid leukemia.
American journal of hematology - 1 Nov 2012
Milosevic Jelena D, Puda Ana, Malcovati Luca, Berg Tiina, Hofbauer Michael, Stukalov Alexey, Klampfl Thorsten, Harutyunyan Ashot S, Gisslinger Heinz, Gisslinger Bettina, Burjanivova Tatiana, Rumi Elisa, Pietra Daniela, Elena Chiara, Vannucchi Alessandro M, Doubek Michael, Dvorakova Dana, Robesova Blanka, Wieser Rotraud, Koller Elisabeth, Suvajdzic Nada, Tomin Dragica, Tosic Natasa, Colinge Jacques, Racil Zdenek, Steurer Michael, Pavlovic Sonja, Cazzola Mario, Kralovics Robert
Abstract excerpt
The study aimed to identify genetic lesions associated with secondary acute myeloid leukemia (sAML) in comparison with AML arising de novo (dnAML) and assess their impact on patients' overall survival (OS). High-resolution genotyping and loss of heterozygosity mapping was performed on DNA samples from 86 sAML and 117 dnAML patients, using Affymetrix Genome-Wide Human SNP 6.0 arrays. Genes TP53, RUNX1, CBL,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
